People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pluri Inc. | — | Biotechnology | Series A | $13.4M | $13.8M | 2022 |
| Medigus Ltd. | — | Biotechnology | Series A | $8.6M | $108.7M | 2015 |
| IceCure Medical Ltd. | — | Biotechnology | Seed | $8.0M | $7.4M | 2013 |
Doron Birger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Doron Birger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ron Mayron | 1 | 6 |
| Jeremy Starkweather | 1 | 4 |
| Doron Cohen | 1 | 3 |
| Yaacov Goldman | 1 | 3 |
| Chen Franco-Yehuda | 1 | 3 |
| Avraham Ben-Tzvi | 1 | 3 |
| Yonatan Malca | 1 | 2 |
| Mark Germain | 1 | 2 |
| Shad Good | 1 | 2 |
| Yang Huang | 1 | 2 |
| William Irby | 1 | 2 |
| Tlalit Bussi Tel-Tzure | 1 | 2 |
| Shay Levav | 1 | 2 |
| Elka Nir | 1 | 2 |
| NIssim Darvish | 1 | 2 |
| Sharon Levita | 1 | 2 |
| Adi Goldin | 1 | 2 |
| Thomas Dempsey | 1 | 2 |
| Merav Nir Dotan | 1 | 2 |
| Vincent Chun Hung Chan | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.